Aveanna Healthcare Holdings Inc

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis

$13.320

-0.482 (-3.62%)At close

Loading chart…
High
13.900
Open
13.900
VWAP
13.50
Vol
2.22M
Mkt Cap
492.49M
Low
13.275
Amount
29.99M
EV/EBITDA, TTM
12.24

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.

AI analysis of Aveanna Healthcare Holdings Inc (AVAH)

buy

Aveanna Healthcare Holdings Inc is a good buy right now due to its current price of $13.32, which is below the analyst price targets of $15 and $16, indicating potential upside of 12.7% to 20.1%. Additionally, the stock has shown strong momentum with a year-to-date change of +64.85% and a recent RSI of 63.57, suggesting it is not overbought. However, a key risk is the insider selling activity, which has increased by 675.38% over the last month, indicating potential concerns among insiders about the stock's future performance.

Valuation Metrics

The current forward P/E ratio for Aveanna Healthcare Holdings Inc (AVAH) is 15.82, compared to its 5-year average forward P/E of 37.48.

Forward P/E

Fair
5Y Average P/E
37.48
Current P/E
15.82
Overvalued
140.20
Undervalued
-65.25

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
11.86
Current EV/EBITDA
12.24
Overvalued
13.41
Undervalued
10.30

Forward P/S

Strongly Overvalued
5Y Average P/S
0.40
Current P/S
1.04
Overvalued
0.63
Undervalued
0.17

Alphio AI Price Scenarios for AVAH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AVAH

$6.77

Scenario price

B

Base

Base · 50%AVAH

$6.66

Scenario price

B

Bear

Bear · 25%AVAH

$6.42

Scenario price

Whales holding AVAH

J

Jaunty Global Limited

+ HoldingAVAH

+4.05%

3M Return

Events Timeline

2026-08-20 (ET)

21:00:00

RBC Capital Prices Deal Within $11.65-$11.90 Range

20:00:00

US Treasury Yields Rise, Dow Drops Over 700 Points

16:30:00

Aveanna Healthcare Launches Secondary Offering of 15 Million Shares

2026-08-13 (ET)

07:30:00

Aveanna Raises FY26 Adjusted EBITDA Outlook to Over $365M

07:30:00

Aveanna Reports Q2 Revenue of $670.48M, Exceeds Expectations

News

AVAH FAQ — answered by Alphio AI

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Aveanna Healthcare Holdings Inc is a good buy right now due to its current price of $13.32, which is below the analyst price targets of $15 and $16, indicating potential upside of 12.7% to 20.1%. Additionally, the stock has shown strong momentum with a year-to-date change of +64.85% and a recent RSI of 63.57, suggesting it is not overbought. However, a key risk is the insider selling activity, which has increased by 675.38% over the last month, indicating potential concerns among insiders about the stock's future performance.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis